Table 1.
Baseline characteristics
| Parameter | Intervention group (n = 39) | Control group (n = 41) |
|---|---|---|
| Female sex [n (%)] | 23 (59.0) | 27 (65.9) |
| Age [years; mean (SD)] | 44.95 (8.43) | 39.34 (11.48) |
| Asthma, duration [years; mean (SD)] | 23.9 (17.2) | 20.9 (14.3) |
| Number of exacerbations treated by oral corticosteroid courses 6 months before inclusion [mean (range)] | 0.13 (0; 4) | 0.02 (0; 1) |
| Smoking status: | ||
| Current [n (%)] | 9 (22.5) | 4 (9.8) |
| Earlier [n (%)] | 8 (20.0) | 12 (29.3) |
| Never [n (%)] | 22 (55.0) | 24 (58.5) |
| Electronic monitoring [n (%)] | 19 (48.7) | 20 (48.8) |
| CARAT total score [points (95% CI)] | 20.36 (17.96–22.76) | 21.29 (19.43–23.15) |
| CARAT upper airways score [points (95% CI)] | 7.46 (6.22–8.70) | 8.27 (7.26–9.27) |
| CARAT lower airways scores [points (95% CI)] | 12.90 (11.24–14.56) | 13.02 (11.74–14.31) |
| MARS-5 score [points (95% CI)] | 20.79 (19.76–21.83) | 21.22 (20.05–22.39) |
| Adherence ICS with dispensing data [% PDC (95% CI)] |
72.58 (65.46–79.70) | 84.73 (77.57–91.88) |